11 unchanged sentences
Second Amendment to Second Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed on June 17, 2022).
−Removed: Fourth Lease Amendment, dated as of October 17, 2022.
+Added: Interim President and CEO Consulting Letter Agreement by and between Ocuphire Pharma, Inc.
+Added: and Richard Rodgers, dated April 20, 2023.
+Added: Non-Employee Director Compensation Policy.
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
8 unchanged sentences
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
+Added: Indicates management contract or compensatory plan.
Documents are furnished not filed.
1 unchanged sentence
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 4, 2022
Ocuphire Pharma, Inc.
−Removed: /s/ Mina Sooch
−Removed: Chief Executive Officer
+Added: /s/ Richard J.
+Added: Interim Chief Executive Officer
(Principal Executive Officer)
/s/ Amy Rabourn
−Removed: Vice President of Finance
+Added: Senior Vice President of Finance
(Principal Financial Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.